|
What is Transfer Factor?
4Life Transfer Factor
products included in 2005 Physician's Desk Reference: For Nonprescription Drugs and Dietary Supplements (PDR)
Sandy, Utah (June 14, 2005)
For the third consecutive
year, 4Life Transfer Factor products were included in the
2005 Physicians' Desk Reference: For Nonprescription
Drugs and Dietary Supplements . Clinicians have
relied on the PDR for 58 years to provide the latest
nonprescription drug and dietary supplement information.
Today the PDR is still considered the standard supplement
guide for physicians and can be found in virtually every
physician's office, hospital, and pharmacy in the United
States.
The PDR is also available to the lay person, providing
access to a selective listing of the most
frequently-referenced nonprescription drugs and dietary
supplements to ensure safe, appropriate selection.
Although the PDR does not publish comprehensive research
results, each product listed contains information on the
relevant testing and clinical studies performed on that
product. The 4Life entry includes a summary of research on
various 4Life Transfer Factor products, demonstrating the
support 4Life Transfer Factor provides to healthy body
systems, structures and functions.
The 2005 PDR listing includes 4Life's latest product,
4Life Transfer Factor RioVida(TM), as well as the complete
family of 13 different 4Life Transfer Factor products.
These products encompass a broad spectrum of increasingly
sophisticated technology and advanced science, including
the discovery and patent of egg yolks as a new source for
transfer factors,
the development of Targeted Transfer
Factor� technology, increases in Natural Killer (NK) cell
function to 283 and 437 percent, and the stabilization of
these messenger molecules in liquid form.
4Life's inclusion in the PDR helps establish its
leadership position in the development, production and
distribution of transfer factor immune support products.
As more and more physicians and customers realize the
effectiveness and support available through 4Life Transfer
Factor products, national and international coverage is
quickly becoming a frequent event.
Purchase Transfer Factor
New Patent Edges Out the Competition
Patent Covers Transfer Factor Manufacturing Processes
Sandy, Utah (May 3, 2005) 4Life Research� announced
today that the U.S. Patent and Trademark Office has issued
a new Transfer Factor� patent to 4Life. The patent, US
Patent No. 6,866,868, deals with the special manufacturing
processes 4Life uses in preparing synergistic combinations
of transfer factors derived from cow
colostrum and chicken
egg yolks. This new patent specifically applies to all of
the 4Life products that contain the
Transfer Factor E-XF�
blend.
William Hennen, Chief Scientific Officer at 4Life,
commented on the new patent, saying, �The techniques we
use allow us to more efficiently and thus more
economically manufacture our 4Life
Transfer Factor�
products. This newly acquired patent gives us a distinct
edge in a competitive marketplace.�
David Lisonbee, Chief Executive Officer of 4Life,
remarked, �The patent recently issued to us further
solidifies our position in the market as the world�s
leading manufacturer of transfer factor products. We�re
pleased to have the protection this patent provides for
the unique processing methods we use to manufacture
4Life
Transfer Factor products. I�m thankful to our Research and
Development team for their dedication and commitment in
bringing this patent to fruition.�
4Life is the world�s foremost leader in the
development, production and distribution of 4Life Transfer
Factor immune support products and was recognized by Inc.
magazine as the fifteenth fastest growing privately-held
company in America
Purchase Transfer Factor
4Life Transfer Factor Now Approved By the Health
Ministry of Russia for use in Hospitals and Clinics!
First Ever Dietary Supplement to be Approved for
Use by Doctors and Hospitals in Russia
SANDY, UT (October 1, 2004) - In an
unprecedented announcement in the history of network
marketing, 4Life announced today that
4Life Transfer
Factor products as immune modulators have been approved
for use in hospitals and clinics in the Russian
Federation. The results of ten separate clinical trials
and two experimental studies on 4Life Transfer Factor
products were combined in a Methodological Document that
was approved by the Ministry of Health, which now allows
doctors to recommend 4Life Transfer Factor Classic and
4Life Transfer Factor Plus� products to their patients.
First Dietary Supplement
Approved for Use by Doctors and Hospitals in Russia
Commenting on this remarkable achievement, David
Lisonbee, CEO of 4Life stated, �To my knowledge, this is
the first time in the history of this industry that a
network marketing company or any other dietary supplement
company has had one of its dietary supplements approved
for use in hospitals in Russia. The Russian Ministry of
Health is the equivalent of the Food and Drug
Administration in the United States. Doctors and
scientists from Russia have been working jointly with
scientists from 4Life for several years to arrive at this
accomplishment. This approval establishes a new roll of
dietary supplements in the Russian health care system.
Remarkable Response from
Russian Academy of Medical Sciences
In another sector of research of 4Life Transfer
Factor, Dr. Kisielevsky of the Russian Academy of Medical
Sciences stated, �The 4Life sample [Transfer Factor
Advanced Formula] activated NK (natural killer) cell
activity more than the Interleukin-2 (IL2) drug we used as
the standard.� This discovery has attracted the attention
of The International Scientific and Technical Center (ISTC)
of Russia.
Scientists from Several
Countries Join Forces for Additional Clinical Studies of
Transfer Factor
The ISTC of Russia is a member of a joint
international project with other health agencies of Japan,
Europe and the US. The objective of the international
project is to combine efforts in finding improved
immunotherapies. Following the discoveries from the NK
cell testing, the scientists of 4Life have been invited to
join the project. 4Life Transfer Factor as an
immune
modulator will be further researched in this international
forum. The cost of the studies will be paid by the ISTC.
| 
